Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr₹2,588 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,209 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,209 Cr
Mar2024₹3,743 Cr
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr
Mar2021₹2,588 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,209 Cr
12.45
Mar2024 ₹3,743 Cr
12.02
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr
11.66
Mar2021 ₹2,588 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,625.9 Cr 2.3% -0% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.3%

-0%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses